Physician profile
Mathew John Libke
NPI 1629042627
$5,772.92
in general payments reported to CMS, 2019-2025
13 companies · $246 in 2025
The $246 reported for 2025 was less than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $332 · 2020: $268 · 2021: $17.38 · 2022: $4,851 · 2023: $42.92 · 2024: $16.41 · 2025: $246.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $213 · Food and Beverage: $91.94.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $212.97 |
| Food and Beverage | $91.94 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $5,168.11 | 2019-2025 | |
| Ethicon US, LLC | $288.62 | 2019-2025 | Vistaseal |
| Davol INC. | $94.54 | 2020-2022 | |
| Tela Bio, INC. | $56.01 | 2019-2023 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) |
| Shire North American Group INC | $38.71 | 2019 | |
| Mallinckrodt Hospital Products INC. | $18.76 | 2020 | |
| Medtronic, INC. | $17.38 | 2021 | |
| Allergan, INC. | $17.18 | 2019 | |
| Covidien LP | $16.88 | 2019 | |
| Smith+Nephew, INC. | $16.41 | 2024 | Renasys Touch, Pico |
| Kci USA, INC. | $14.50 | 2019 | |
| Boston Scientific Corporation | $13.90 | 2020 | |
| Merck Sharp & Dohme LLC | $11.92 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mathew Libke listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.